Methyl 3-(((methoxycarbonyl)oxy)methyl)-1H-indole-1-carboxylate, 97%, 100mg

7-chloro-1H,4H-pyrido[2,3-d]pyrimidin-4-one, 98%, 1g

(2-thienylmethyl)hydrazine hydrochloride, 95.0%, 250mg

4-[(2-Methoxyphenyl)methyl]oxan-4-amine, 1g

Ethyl 4-(4-n-Propylphenyl)-4-oxobutanoate, 97.0%, 5g

N-((2S,3S,5S)-5-Amino-3-hydroxy-1,6-diphenylhexan-2-yl)-2-(2,6-dimethylphenoxy)acetamide hydrochloride, 97%, 250mg

1,3-Dibromoazulene>98.0%(GC)200mg

7-Aminoheptanoic acid ethyl ester hydrochloride, 95.0%, 10g

(R)-5-(2-(2,5-Difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amine, 97%, 1g

4-Fluorothiophene-2-carboxylic acid, 95.0%, 100mg

3,5-Dihydroxypyridine, 95.0%, 5g

Colonna capillare per GC ROTI®Cap-5 MS Ultra, 25 m, 0.32 mm, 1.00 µm, 1 Pezzo(i)

1-Bromo-2,5-dichlorobenzene, 98.0%, 1g